Abstract
Synthetic biology has the potential to revolutionize human health standards. Advances in molecular and cellular biology, computational science, and systems biology have contributed to this new field that is trying to apply engineering principles to answer biological questions. These applications of synthetic biology may bring hope to our battle against the ever-emerging drug-resistant forms of disease. Advances in medical science helped us to achieve early victory against various common diseases in the last century. However, newer forms of drug-resistant diseases have emerged and are threatening the human race immensely. To fight this challenge, several strategies have been adopted to various degrees of success. For some diseases such as cancer, tuberculosis, HIV/AIDS, malaria, and diabetes, the threat is still imminent. This chapter discusses the early efforts of synthetic biologists toward better management, wherein we summarize some of the very recent work in the field. We hope the arsenal of synthetic solutions will provide superior solutions toward early diagnosis and treatment of drug-resistant disease forms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ackerman SE, Currier NV, Bergen JM, Cochran JR (2014) Cystine-knot peptides: emerging tools for cancer imaging and therapy. Expert Rev Proteomics 11:561–572. doi:10.1586/14789450.2014.932251
Altimari JM, Hockey SC, Boshoff HI, Sajid A, Henderson LC (2015) Novel 1,4-substituted-1,2,3-triazoles as antitubercular agents. ChemMedChem 10:787–791. doi:10.1002/cmdc.201500051
Arora G, Sajid A, Gupta M, Bhaduri A, Kumar P, Basu-Modak S, Singh Y (2010) Understanding the role of PknJ in Mycobacterium tuberculosis: biochemical characterization and identification of novel substrate pyruvate kinase A. PLoS One 5:e10772. doi:10.1371/journal.pone.0010772
Burbelo PD, Issa AT, Ching KH, Cohen JI, Iadarola MJ, Marques A (2010) Rapid, simple, quantitative, and highly sensitive antibody detection for lyme disease. Clin Vaccine Immunol 17:904–909. doi:10.1128/CVI.00476-09
Burfield L, Burden AD (2013) Psoriasis. J R Coll Phys Edinb 43:334–338. doi:10.4997/JRCPE.2013.414
Busard C, Zweegers J, Limpens J, Langendam M, Spuls PI (2014) Combined use of systemic agents for psoriasis: a systematic review. JAMA Dermatol 150:1213–1220. doi:10.1001/jamadermatol.2014.1111
Chakravarti D, Wong WW (2015) Synthetic biology in cell-based cancer immunotherapy. Trends Biotechnol 33:449–461. doi:10.1016/j.tibtech.2015.05.001
Chanishvili N (2012) Phage therapy--history from Twort and d’Herelle through Soviet experience to current approaches. Adv Virus Res 83:3–40. doi:10.1016/B978-0-12-394438-2.00001-3
Chen R (2015) The sweet branch of metabolic engineering: cherry-picking the low-hanging sugary fruits. Microb Cell Fact 14:197. doi:10.1186/s12934-015-0389-z
Christiansen MN, Chik J, Lee L, Anugraham M, Abrahams JL, Packer NH (2014) Cell surface protein glycosylation in cancer. Proteomics 14:525–546. doi:10.1002/pmic.201300387
Clokie MR, Millard AD, Letarov AV, Heaphy S (2011) Phages in nature. Bacteriophage 1:31–45. doi:10.4161/bact.1.1.14942
Colgrave ML, Craik DJ (2004) Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry 43:5965–5975. doi:10.1021/bi049711q
Craik DJ, Cemazar M, Wang CK, Daly NL (2006) The cyclotide family of circular miniproteins: nature’s combinatorial peptide template. Biopolymers 84:250–266. doi:10.1002/bip.20451
Delves PJ (1998) The role of glycosylation in autoimmune disease. Autoimmunity 27:239–253. doi:10.3109/08916939808993836
d’Espaux L, Mendez-Perez D, Li R, Keasling JD (2015) Synthetic biology for microbial production of lipid-based biofuels. Curr Opin Chem Biol 29:58–65. doi:10.1016/j.cbpa.2015.09.009
Drobniewski F, Cooke M, Jordan J, Casali N, Mugwagwa T, Broda A, Townsend C, Sivaramakrishnan A, Green N, Jit M, Lipman M, Lord J, White PJ, Abubakar I (2015) Systematic review, meta-analysis and economic modelling of molecular diagnostic tests for antibiotic resistance in tuberculosis. Health Technol Assess 19:1–188, vii–viii. doi:10.3310/hta19340
Freeze HH, Eklund EA, Ng BG, Patterson MC (2015) Neurological aspects of human glycosylation disorders. Annu Rev Neurosci 38:105–125. doi:10.1146/annurev-neuro-071714-034019
Funakoshi Y, Suzuki T (2009) Glycobiology in the cytosol: the bitter side of a sweet world. Biochim Biophys Acta 1790:81–94. doi:10.1016/j.bbagen.2008.09.009
Glasscock CJ, Lucks JB, DeLisa MP (2016) Engineered protein machines: emergent tools for synthetic biology. Cell Chem Biol 23:45–56. doi:10.1016/j.chembiol.2015.12.004
Goulabchand R, Vincent T, Batteux F, Eliaou JF, Guilpain P (2014) Impact of autoantibody glycosylation in autoimmune diseases. Autoimmun Rev 13:742–750. doi:10.1016/j.autrev.2014.02.005
Green AA, Silver PA, Collins JJ, Yin P (2014) Toehold switches: de-novo-designed regulators of gene expression. Cell 159:925–939. doi:10.1016/j.cell.2014.10.002
Guerra-Doce E (2015) Psychoactive substances in prehistoric times: examining the archaeological evidence. Time Mind 8:91–112. doi:10.1080/1751696X.2014.993244
Gupta MA, Simpson FC, Gupta AK (2015) Psoriasis and sleep disorders: a systematic review. Sleep Med Rev 29:63–75. doi:10.1016/j.smrv.2015.09.003
Hatfull GF (2014a) Molecular genetics of mycobacteriophages. Microbiol Spectr 2:1–36. doi:10.1128/microbiolspec.MGM2-0032-2013
Hatfull GF (2014b) Mycobacteriophages: windows into tuberculosis. PLoS Pathog 10:e1003953. doi:10.1371/journal.ppat.1003953
Hedt BL, Laufer MK, Cohen T (2011) Drug resistance surveillance in resource-poor settings: current methods and considerations for TB, HIV, and malaria. Am J Trop Med Hyg 84:192–199. doi:10.4269/ajtmh.2011.10-0363
Henriques ST, Huang YH, Chaousis S, Sani MA, Poth AG, Separovic F, Craik DJ (2015) The prototypic cyclotide Kalata B1 has a unique mechanism of entering cells. Chem Biol 22:1087–1097. doi:10.1016/j.chembiol.2015.07.012
Her M, Kavanaugh A (2016) Alterations in immune function with biologic therapies for autoimmune disease. J Allergy Clin Immunol 137:19–27. doi:10.1016/j.jaci.2015.10.023
Jassim SA, Limoges RG (2014) Natural solution to antibiotic resistance: bacteriophages ‘The Living Drugs’. World J Microbiol Biotechnol 30:2153–2170. doi:10.1007/s11274-014-1655-7
Kalos M, Levine BL, Porter DL, Katz S, Grupp SA, Bagg A, June CH (2011) T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci Transl Med 3:95ra73. doi:10.1126/scitranslmed.3002842
Keasling JD (2010) Manufacturing molecules through metabolic engineering. Science 330:1355–1358. doi:10.1126/science.1193990
Lang K, Chin JW (2014) Cellular incorporation of unnatural amino acids and bioorthogonal labeling of proteins. Chem Rev 114:4764–4806. doi:10.1021/cr400355w
Lang K, Davis L, Chin JW (2015) Genetic encoding of unnatural amino acids for labeling proteins. Methods Mol Biol 1266:217–228. doi:10.1007/978-1-4939-2272-7_15
Laxminarayan R, Duse A, Wattal C, Zaidi AK, Wertheim HF, Sumpradit N, Vlieghe E, Hara GL, Gould IM, Goossens H, Greko C, So AD, Bigdeli M, Tomson G, Woodhouse W, Ombaka E, Peralta AQ, Qamar FN, Mir F, Kariuki S, Bhutta ZA, Coates A, Bergstrom R, Wright GD, Brown ED, Cars O (2013) Antibiotic resistance-the need for global solutions. Lancet Infect Dis 13:1057–1098. doi:10.1016/S1473-3099(13)70318-9
Leekha S, Terrell CL, Edson RS (2011) General principles of antimicrobial therapy. Mayo Clin Proc 86:156–167. doi:10.4065/mcp.2010.0639
Lim WA (2010) Designing customized cell signalling circuits. Nat Rev Mol Cell Biol 11:393–403. doi:10.1038/nrm2904
Lowes MA, Suarez-Farinas M, Krueger JG (2014) Immunology of psoriasis. Annu Rev Immunol 32:227–255. doi:10.1146/annurev-immunol-032713-120225
Lu TK, Collins JJ (2009) Engineered bacteriophage targeting gene networks as adjuvants for antibiotic therapy. Proc Natl Acad Sci USA 106:4629–4634. doi:10.1073/pnas.0800442106
Lucks JB, Qi L, Whitaker WR, Arkin AP (2008) Toward scalable parts families for predictable design of biological circuits. Curr Opin Microbiol 11:567–573. doi:10.1016/j.mib.2008.10.002
Marais BJ (2016) The global tuberculosis situation and the inexorable rise of drug-resistant disease. Adv Drug Deliv Rev. doi:10.1016/j.addr.2016.01.021
McFarlane M (1991) It’s time to manage your time. Dermatol Nurs 3(172):182
McNerney R, Wilson SM, Sidhu AM, Harley VS, al Suwaidi Z, Nye PM, Parish T, Stoker NG (1998) Inactivation of mycobacteriophage D29 using ferrous ammonium sulphate as a tool for the detection of viable Mycobacterium smegmatis and M. tuberculosis. Res Microbiol 149:487–495. doi:10.1016/S0923-2508(98)80003-X
Moura M, Finkle J, Stainbrook S, Greene J, Broadbelt LJ, Tyo KE (2016) Evaluating enzymatic synthesis of small molecule drugs. Metab Eng 33:138–147. doi:10.1016/j.ymben.2015.11.006
Pai M, Kalantri S, Pascopella L, Riley LW, Reingold AL (2005) Bacteriophage-based assays for the rapid detection of rifampicin resistance in Mycobacterium tuberculosis: a meta-analysis. J Infect 51:175–187. doi:10.1016/j.jinf.2005.05.017
Pardee K, Green AA, Ferrante T, Cameron DE, DaleyKeyser A, Yin P, Collins JJ (2014) Paper-based synthetic gene networks. Cell 159:940–954. doi:10.1016/j.cell.2014.10.004
Park DJ, Drobniewski FA, Meyer A, Wilson SM (2003) Use of a phage-based assay for phenotypic detection of mycobacteria directly from sputum. J Clin Microbiol 41:680–688. doi:10.1128/JCM.41.2.680-688.2003
Pope WH, Hatfull GF (2015) Adding pieces to the puzzle: new insights into bacteriophage diversity from integrated research-education programs. Bacteriophage 5:e1084073. doi:10.1080/21597081.2015.1084073
Poth AG, Chan LY, Craik DJ (2013) Cyclotides as grafting frameworks for protein engineering and drug design applications. Biopolymers 100:480–491. doi:10.1002/bip.22284
Rifat M, Hall J, Oldmeadow C, Husain A, Milton AH (2015) Health system delay in treatment of multidrug resistant tuberculosis patients in Bangladesh. BMC Infect Dis 15:526. doi:10.1186/s12879-015-1253-9
Rybniker J, Kramme S, Small PL (2006) Host range of 14 mycobacteriophages in Mycobacterium ulcerans and seven other mycobacteria including Mycobacterium tuberculosis--application for identification and susceptibility testing. J Med Microbiol 55:37–42. doi:10.1099/jmm.0.46238-0
Sajid A, Arora G, Singhal A, Kalia VC, Singh Y (2015) Protein phosphatases of pathogenic bacteria: role in physiology and virulence. Annu Rev Microbiol 69:527–547. doi:10.1146/annurev-micro-020415-111342
Salmond GP, Fineran PC (2015) A century of the phage: past, present and future. Nat Rev Microbiol 13:777–786. doi:10.1038/nrmicro3564
Samaddar S, Grewal RK, Sinha S, Ghosh S, Roy S, Das Gupta SK (2015) Dynamics of mycobacteriophage-mycobacterial host interaction: evidence for secondary mechanisms for host lethality. Appl Environ Microbiol 82:124–133. doi:10.1128/AEM.02700-15
Schofield DA, Sharp NJ, Westwater C (2012) Phage-based platforms for the clinical detection of human bacterial pathogens. Bacteriophage 2:105–283. doi:10.4161/bact.19274
Schukur L, Geering B, Charpin-El Hamri G, Fussenegger M (2015) Implantable synthetic cytokine converter cells with AND-gate logic treat experimental psoriasis. Sci Transl Med 7:318ra201. doi:10.1126/scitranslmed.aac4964
Schukur L, Geering B, Fussenegger M (2016) Human whole-blood culture system for ex vivo characterization of designer-cell function. Biotechnol Bioeng 113:588–597. doi:10.1002/bit.25828
Schutz V, Mootz HD (2014) Click-tag and amine-tag: chemical tag approaches for efficient protein labeling in vitro and on live cells using the naturally split Npu DnaE intein. Angew Chem Int Ed Engl 53:4113–4117. doi:10.1002/anie.201309396
Seed KD (2015) Battling phages: how bacteria defend against viral attack. PLoS Pathog 11:e1004847. doi:10.1371/journal.ppat.1004847
Singhal A, Arora G, Virmani R, Kundu P, Khanna T, Sajid A, Misra R, Joshi J, Yadav V, Samanta S, Saini N, Pandey AK, Visweswariah SS, Hentschker C, Becher D, Gerth U, Singh Y (2015) Systematic analysis of mycobacterial acylation reveals first example of acylation-mediated regulation of enzyme activity of a bacterial phosphatase. J Biol Chem 290:26218–26234. doi:10.1074/jbc.M115.687269
Smartt AE, Xu T, Jegier P, Carswell JJ, Blount SA, Sayler GS, Ripp S (2012) Pathogen detection using engineered bacteriophages. Anal Bioanal Chem 402:3127–3146. doi:10.1007/s00216-011-5555-5
Smith HO, Hutchison CA 3rd, Pfannkoch C, Venter JC (2003) Generating a synthetic genome by whole genome assembly: phiX174 bacteriophage from synthetic oligonucleotides. Proc Natl Acad Sci USA 100:15440–15445. doi:10.1073/pnas.2237126100
Stauss HJ, Morris EC (2013) Immunotherapy with gene-modified T cells: limiting side effects provides new challenges. Gene Ther 20:1029–1032. doi:10.1038/gt.2013.34
Sugimoto K, Yasujima M, Yagihashi S (2008) Role of advanced glycation end products in diabetic neuropathy. Curr Pharm Des 14:953–961. doi:10.2174/138161208784139774
Toussaint AJ, Muschel LH (1959) Neutralization of bacteriophage by normal serum. Nature 183:1825–1827. doi:10.1038/1831825a0
Trosset JY, Carbonell P (2015) Synthetic biology for pharmaceutical drug discovery. Drug Des Devel Ther 9:6285–6302. doi:10.2147/DDDT.S58049
Twort FW (1915) An investigation on the nature of ultra-microscopic viruses. Lancet 2:1241–1243. doi:10.1016/S0140-6736(01)20383-3
Varki A, Kannagi R, Toole BP (2009) Glycosylation changes in cancer. In: Varki A, Cummings RD, Esko JD, et al (eds) Essentials of glycobiology, Chap 44, 2nd edn. Cold Spring Harbor Laboratory Press, New York. http://www.ncbi.nlm.nih.gov/books/NBK1963/
Velasquez GE, Becerra MC, Gelmanova IY, Pasechnikov AD, Yedilbayev A, Shin SS, Andreev YG, Yanova G, Atwood SS, Mitnick CD, Franke MF, Rich ML, Keshavjee S (2014) Improving outcomes for multidrug-resistant tuberculosis: aggressive regimens prevent treatment failure and death. Clin Infect Dis 59:9–15. doi:10.1093/cid/ciu209
Weber W, Schoenmakers R, Keller B, Gitzinger M, Grau T, Daoud-El Baba M, Sander P, Fussenegger M (2008) A synthetic mammalian gene circuit reveals antituberculosis compounds. Proc Natl Acad Sci USA 105:9994–9998. doi:10.1073/pnas.0800663105
Wei H (2015) Bacteriophages, revitalized after 100 years in the shadow of antibiotics. Virol Sin 30:1–2. doi:10.1007/s12250-014-3562-y
WHO global tuberculosis report (2015) http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf?ua=1
Wilson JW, Tsukayama DT (2016) Extensively drug-resistant tuberculosis: principles of resistance, diagnosis, and management. Mayo Clin Proc. doi:10.1016/j.mayocp.2016.01.014
Wright GD (2012) Antibiotics: a new hope. Chem Biol 19:3–10. doi:10.1016/j.chembiol.2011.10.019
Wu CY, Roybal KT, Puchner EM, Onuffer J, Lim WA (2015) Remote control of therapeutic T cells through a small molecule-gated chimeric receptor. Science 350:aab4077. doi:10.1126/science.aab4077
Yates TA, Khan PY, Knight GM, Taylor JG, McHugh TD, Lipman M, White RG, Cohen T, Cobelens FG, Wood R, Moore DA, Abubakar I (2016) The transmission of Mycobacterium tuberculosis in high burden settings. Lancet Infect Dis 16:227–238. doi:10.1016/S1473-3099(15)00499-5
Author information
Authors and Affiliations
Corresponding authors
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Arora, G., Misra, R., Sajid, A. (2017). Synthetic Solutions to Drug Resistance. In: Arora, G., Sajid, A., Kalia, V. (eds) Drug Resistance in Bacteria, Fungi, Malaria, and Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-48683-3_26
Download citation
DOI: https://doi.org/10.1007/978-3-319-48683-3_26
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-48682-6
Online ISBN: 978-3-319-48683-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)